Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | LND101 |
| Trade Name | |
| Synonyms | LND-101|LND 101 |
| Drug Descriptions |
LND101 is a microbiome therapy derived from healthy donors, which may enhance antitumor immune response (Journal for ImmunoTherapy of Cancer 2024;12). |
| DrugClasses | Microbiome 9 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| LND101 | LND101 | 0 | 0 |
| LND101 + unspecified immune checkpoint inhibitor | LND101 unspecified immune checkpoint inhibitor | 0 | 1 |